Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Junctional Epidermolysis Bullosa 1 by Holostem Terapie Avanzate for Epidermolysis Bullosa: Likelihood of Approval
Junctional Epidermolysis Bullosa 1 is under clinical development by Holostem Terapie Avanzate and currently in Phase II for Epidermolysis Bullosa....